USANA Health Sciences, Inc. (NYSE:USNA) Shares Acquired by Strs Ohio

Strs Ohio lifted its position in USANA Health Sciences, Inc. (NYSE:USNA) by 9.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,900 shares of the company’s stock after acquiring an additional 1,000 shares during the period. Strs Ohio owned 0.06% of USANA Health Sciences worth $637,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in USNA. SG Americas Securities LLC acquired a new position in shares of USANA Health Sciences in the 3rd quarter valued at $581,000. Denali Advisors LLC increased its position in shares of USANA Health Sciences by 16.9% in the 3rd quarter. Denali Advisors LLC now owns 47,129 shares of the company’s stock valued at $2,762,000 after acquiring an additional 6,800 shares during the period. Robeco Institutional Asset Management B.V. increased its position in shares of USANA Health Sciences by 27.0% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 23,819 shares of the company’s stock valued at $1,396,000 after acquiring an additional 5,064 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its position in USANA Health Sciences by 60.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock worth $198,000 after purchasing an additional 1,274 shares during the period. Finally, TD Asset Management Inc grew its position in USANA Health Sciences by 16.2% during the 3rd quarter. TD Asset Management Inc now owns 8,600 shares of the company’s stock worth $504,000 after purchasing an additional 1,200 shares during the period. 54.25% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

USNA has been the topic of several analyst reports. DA Davidson cut their price target on USANA Health Sciences from $53.00 to $48.00 and set a “neutral” rating on the stock in a research report on Thursday, February 22nd. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Friday, January 12th.

Insider Transactions at USANA Health Sciences

In other news, COO Walter Noot sold 5,240 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $49.05, for a total transaction of $257,022.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, insider David Mulham Mulham sold 4,311 shares of the firm’s stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $47.76, for a total value of $205,893.36. Following the transaction, the insider now directly owns 7,825 shares of the company’s stock, valued at approximately $373,722. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO Walter Noot sold 5,240 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $49.05, for a total transaction of $257,022.00. The disclosure for this sale can be found here. Insiders have sold a total of 24,807 shares of company stock valued at $1,200,791 in the last ninety days. 0.33% of the stock is currently owned by corporate insiders.

USANA Health Sciences Stock Performance

Shares of USNA opened at $43.47 on Friday. The business’s 50-day moving average is $47.18 and its two-hundred day moving average is $48.88. USANA Health Sciences, Inc. has a fifty-two week low of $42.59 and a fifty-two week high of $69.60. The company has a market capitalization of $836.41 million, a P/E ratio of 13.17, a P/E/G ratio of 1.34 and a beta of 0.91.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, February 6th. The company reported $0.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.35. USANA Health Sciences had a net margin of 6.93% and a return on equity of 13.49%. The business had revenue of $221.08 million for the quarter, compared to analyst estimates of $206.70 million. Analysts forecast that USANA Health Sciences, Inc. will post 2.73 EPS for the current year.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.